Task: Answer the multiple-choice question.
Query: Which drug exhibits a 34.013% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a CCC(C)NC(=O)c1cc(S(=O)(=O)N2CCCCC2)c[nH]1
b CCOC(=O)c1ccc(NC(=O)CC2SCCNC2=O)cc1
Answer: a. CCC(C)NC(=O)c1cc(S(=O)(=O)N2CCCCC2)c[nH]1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)NC(=O)c1cc(S(=O)(=O)N2CCCCC2)c[nH]1
CCC(C)NC(=O)c1cc(S(=O)(=O)N2CCCCC2)c[nH]1
N-butan-2-yl-4-piperidin-1-ylsulfonyl-1H-pyrrole-2-carboxamide